Loading…

S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research

Summary Elevated blood levels of S100B in neuropsychiatric disorders have so far been mainly attributed to glial pathologies. However, increases or dysfunction of adipose tissue may be alternatively responsible. Our study assessed S100B serum levels in 60 adult subjects without a prior history of ne...

Full description

Saved in:
Bibliographic Details
Published in:Psychoneuroendocrinology 2010-02, Vol.35 (2), p.321-324
Main Authors: Steiner, Johann, Schiltz, Kolja, Walter, Martin, Wunderlich, Michael T, Keilhoff, Gerburg, Brisch, Ralf, Bielau, Hendrik, Bernstein, Hans-Gert, Bogerts, Bernhard, Schroeter, Matthias L, Westphal, Sabine
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Elevated blood levels of S100B in neuropsychiatric disorders have so far been mainly attributed to glial pathologies. However, increases or dysfunction of adipose tissue may be alternatively responsible. Our study assessed S100B serum levels in 60 adult subjects without a prior history of neuropsychiatric disorders. S100B concentrations were closely correlated with the body mass index (BMI, range 18–45 kg/m2 ) as well as levels of leptin and adipocyte-type fatty acid-binding protein (A-FABP/FABP4) that are well-known adipose-related factors. Effect sizes as measured by Cohen's d indicated medium (0.8 > d > 0.5) to strong effects ( d > 0.9) of BMI on S100B blood levels. In conclusion, physiological S100B levels in humans appear to closely reflect adipose tissue mass, which should therefore be considered as an important confounding factor in clinical studies examining the role of S100B.
ISSN:0306-4530
1873-3360
DOI:10.1016/j.psyneuen.2009.07.012